Exactech Launches Advanced Predict+® Tool for Personalized Shoulder Surgery Outcomes Prediction
Exactech Unveils Enhanced Predict+®
Exactech, a leader in medical technology, has made significant strides in orthopedic surgery with the introduction of the next generation of their innovative tool, Predict+®. This advanced clinical decision support system leverages the capabilities of machine learning to analyze clinical data, CT images, and provide personalized predictions for patients undergoing both anatomic and reverse total shoulder arthroplasty.
Transformation in Clinical Decision-Making
Available now in regions including Europe and Australia, the latest version of Predict+® is intricately woven into the recent updates of the Shoulder Planning App. Notable enhancements encompass tools for osteophyte removal, automated joint measurements, and a user-friendly interface. This integration not only streamlines clinical workflows but also significantly reduces the amount of manual input required from healthcare professionals, promoting efficiency in patient assessments.
Chris Roche, Senior Vice President of Extremities at Exactech, expressed pride in the company's leadership within the orthopedic AI sector. He stated, "We are proud to release the next generation of Predict+, the first machine learning-based clinical decision support tool for shoulder arthroplasty. Our initiative, originating in 2020, aimed to assist surgeons in accurately forecasting patient improvements post-surgery. With this new generation, we've taken personalization a notch higher, incorporating even more patient-specific data from the Shoulder Planning App."
Patient Engagement and Satisfaction
The ability to provide tangible expectations regarding clinical outcomes is crucial for aligning patient and surgeon goals. Enhanced by Predict+, this alignment can substantially elevate patient satisfaction following shoulder surgeries. According to Malin Wijeratna, a consultant orthopedic surgeon from Northampton General Hospital, the reliability of Predict+ has been invaluable.
"Using Predict+ has allowed me to set realistic expectations for my patients regarding their post-replacement improvements. The integration of CT planning into the software streamlines my clinical workflow, paving the way for personalized outcomes that may become a fundamental element of the patient-decision making discussion," Wijeratna remarked.
Additionally, Pierre Abadie, a shoulder surgeon at Clinique du Sport, noted the tool's effectiveness in fostering patient-surgeon relationships, asserting its role in clarifying objectives during preoperative consultations while aiding in postoperative progress tracking.
A Look Ahead
Vikas Kumar, Vice President of Machine Learning at Exactech, highlighted the significance of integrating image data with clinical datasets. This integration represents a major evolution for Predict+, enhancing the quality of outcome predictions and ensuring more patients can achieve their desired results over time.
The company's commitment extends into their broader Active Intelligence® ecosystem, which aims to empower surgeons with precise, data-driven insights for better outcomes. To learn more about Predict+® and the full suite of Exactech technologies, visit their website at www.ExactechAI.com.
Note: Predict+® is currently awaiting FDA marketing authorization.
About Exactech
Exactech is a prominent global medical technology innovator focused on providing orthopedic surgeons with state-of-the-art implants, surgical instruments, and a comprehensive suite of Active Intelligence® solutions. The company's commitment to enhancing patient mobility is evident across its product lines. More information can be found on their website or their social platforms, including LinkedIn and Instagram.